Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:593291.
doi: 10.4061/2011/593291. Epub 2011 Jun 28.

Hepatitis C and kidney transplantation

Marco Carbone  1 , Paul Cockwell, James Neuberger
Affiliations

Hepatitis C and kidney transplantation

Marco Carbone et al. Int J Nephrol. 2011.

Abstract

Hepatitis C virus (HCV) infection is relatively common among patients with end-stage kidney disease (ESKD) on dialysis and kidney transplant recipients. HCV infection in hemodialysis patients is associated with an increased mortality due to liver cirrhosis and hepatocellular carcinoma. The severity of hepatitis C-related liver disease in kidney transplant candidates may predict patient and graft survival after transplant. Liver biopsy remains the gold standard in the assessment of liver fibrosis in this setting. Kidney transplantation, not haemodialysis, seems to be the best treatment for HCV+ve patients with ESKD. Transplantation of kidneys from HCV+ve donors restricted to HCV+ve recipients is safe and associated with a reduction in the waiting time. Simultaneous kidney/liver transplantation (SKL) should be considered for kidney transplant candidates with HCV-related decompensated cirrhosis. Treatment of HCV is more complex in hemodialysis patients, whereas treatment of HCV recurrence in SLK recipients appears effective and safe.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of Hepatitis C Infection. Data source: World Health Organization. (Modified from [5].)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Lauer GM, Walker BD. Hepatitis C virus infection. New England Journal of Medicine. 2001;345(1):41–52. - PubMed
    1. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. The Lancet. 2008;371(9631):2173–2182. - PubMed
    1. Scott DR, Wong JK, Spicer TS, et al. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand. Transplantation. 2010;90(11):1165–1171. - PubMed
    1. Goodkin DA, Bragg-Gresham JL, Koenig K, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the dialysis outcomes and practice patterns study (DOPPS) Journal of the American Society of Nephrology. 2003;14(12):3270–3277. - PubMed
    1. Perz JF, Farrington LA, Pecoraro C. Estimated global prevalence of hepatitis C virus infection. In: Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America; September-October 2004; Boston, Mass, USA.

LinkOut - more resources